vs
Side-by-side financial comparison of Navitas Semiconductor Corp (NVTS) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
Spero Therapeutics, Inc. is the larger business by last-quarter revenue ($12.6M vs $7.3M, roughly 1.7× Navitas Semiconductor Corp). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs -436.1%, a 686.7% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs -59.4%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs -43.9%).
Navitas Semiconductor Corp is a leading global semiconductor firm specializing in gallium nitride (GaN) power integrated circuits. Its high-efficiency, compact power solutions serve consumer electronics, electric vehicles, renewable energy, and industrial sectors, with clients spanning North America, Asia, and Europe.
NVTS vs SPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.3M | $12.6M |
| Net Profit | $-31.8M | $31.5M |
| Gross Margin | 38.1% | — |
| Operating Margin | -567.3% | — |
| Net Margin | -436.1% | 250.7% |
| Revenue YoY | -59.4% | 24080.8% |
| Net Profit YoY | 20.2% | 250.9% |
| EPS (diluted) | $-0.14 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.3M | $12.6M | ||
| Q3 25 | $10.1M | $0 | ||
| Q2 25 | $14.5M | $0 | ||
| Q1 25 | $14.0M | $12.0K | ||
| Q4 24 | $18.0M | $52.0K | ||
| Q3 24 | $21.7M | $65.0K | ||
| Q2 24 | $20.5M | $114.0K | ||
| Q1 24 | $23.2M | $140.0K |
| Q4 25 | $-31.8M | $31.5M | ||
| Q3 25 | $-19.2M | $-7.4M | ||
| Q2 25 | $-49.1M | $-1.7M | ||
| Q1 25 | $-16.8M | $-13.9M | ||
| Q4 24 | $-39.9M | — | ||
| Q3 24 | $-18.7M | $-17.1M | ||
| Q2 24 | $-22.3M | $-17.9M | ||
| Q1 24 | $-3.7M | $-12.7M |
| Q4 25 | 38.1% | — | ||
| Q3 25 | 37.9% | — | ||
| Q2 25 | 16.1% | — | ||
| Q1 25 | 37.9% | — | ||
| Q4 24 | 12.4% | — | ||
| Q3 24 | 39.7% | — | ||
| Q2 24 | 39.0% | — | ||
| Q1 24 | 41.1% | — |
| Q4 25 | -567.3% | — | ||
| Q3 25 | -192.0% | — | ||
| Q2 25 | -149.4% | — | ||
| Q1 25 | -180.5% | -122758.3% | ||
| Q4 24 | -216.9% | — | ||
| Q3 24 | -133.6% | -28604.6% | ||
| Q2 24 | -152.1% | -16720.2% | ||
| Q1 24 | -136.2% | -9987.1% |
| Q4 25 | -436.1% | 250.7% | ||
| Q3 25 | -190.2% | — | ||
| Q2 25 | -338.7% | — | ||
| Q1 25 | -120.1% | -115550.0% | ||
| Q4 24 | -221.7% | — | ||
| Q3 24 | -86.4% | -26380.0% | ||
| Q2 24 | -109.1% | -15668.4% | ||
| Q1 24 | -15.9% | -9049.3% |
| Q4 25 | $-0.14 | $0.56 | ||
| Q3 25 | $-0.09 | $-0.13 | ||
| Q2 25 | $-0.25 | $-0.03 | ||
| Q1 25 | $-0.09 | $-0.25 | ||
| Q4 24 | $-0.22 | — | ||
| Q3 24 | $-0.10 | $-0.32 | ||
| Q2 24 | $-0.12 | $-0.33 | ||
| Q1 24 | $-0.02 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $236.9M | $40.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $443.7M | $59.0M |
| Total Assets | $500.5M | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $236.9M | $40.3M | ||
| Q3 25 | $150.6M | $48.6M | ||
| Q2 25 | $161.2M | $31.2M | ||
| Q1 25 | $75.1M | $48.9M | ||
| Q4 24 | $86.7M | $52.9M | ||
| Q3 24 | $98.3M | $76.3M | ||
| Q2 24 | $111.7M | $63.5M | ||
| Q1 24 | $128.9M | $82.3M |
| Q4 25 | $443.7M | $59.0M | ||
| Q3 25 | $371.0M | $26.5M | ||
| Q2 25 | $388.9M | $32.8M | ||
| Q1 25 | $341.8M | $33.8M | ||
| Q4 24 | $348.0M | $46.1M | ||
| Q3 24 | $380.8M | $65.5M | ||
| Q2 24 | $388.1M | $80.5M | ||
| Q1 24 | $397.9M | $96.2M |
| Q4 25 | $500.5M | $68.9M | ||
| Q3 25 | $430.2M | $54.2M | ||
| Q2 25 | $449.4M | $62.1M | ||
| Q1 25 | $370.8M | $77.7M | ||
| Q4 24 | $390.0M | $110.5M | ||
| Q3 24 | $419.4M | $135.2M | ||
| Q2 24 | $439.1M | $149.9M | ||
| Q1 24 | $467.9M | $167.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.1M | $-8.4M |
| Free Cash FlowOCF − Capex | $-8.2M | — |
| FCF MarginFCF / Revenue | -111.8% | — |
| Capex IntensityCapex / Revenue | 0.7% | — |
| Cash ConversionOCF / Net Profit | — | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | $-44.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.1M | $-8.4M | ||
| Q3 25 | $-10.0M | $17.4M | ||
| Q2 25 | $-11.2M | $-17.7M | ||
| Q1 25 | $-13.5M | $-4.0M | ||
| Q4 24 | $-10.2M | $-23.4M | ||
| Q3 24 | $-13.7M | $12.8M | ||
| Q2 24 | $-15.1M | $-18.7M | ||
| Q1 24 | $-19.8M | $5.9M |
| Q4 25 | $-8.2M | — | ||
| Q3 25 | $-10.7M | — | ||
| Q2 25 | $-11.9M | — | ||
| Q1 25 | $-13.6M | — | ||
| Q4 24 | $-10.8M | — | ||
| Q3 24 | $-14.3M | — | ||
| Q2 24 | $-17.9M | — | ||
| Q1 24 | $-22.7M | — |
| Q4 25 | -111.8% | — | ||
| Q3 25 | -106.1% | — | ||
| Q2 25 | -82.2% | — | ||
| Q1 25 | -96.8% | — | ||
| Q4 24 | -59.8% | — | ||
| Q3 24 | -65.9% | — | ||
| Q2 24 | -87.3% | — | ||
| Q1 24 | -97.9% | — |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 7.0% | — | ||
| Q2 25 | 4.7% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 2.6% | — | ||
| Q2 24 | 13.4% | — | ||
| Q1 24 | 12.5% | — |
| Q4 25 | — | -0.26× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
